Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1Breast 1

Conditions

Malignant Neoplasms of Male Genital Organs 1Carcinoma, Renal Cell 1Breast Neoplasms 1Agnosia 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Clonidine × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

NCT02740127 2022-01-24

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

M.D. Anderson Cancer Center

Phase 3 Completed
52 enrolled 7 charts
Other neoplasm

Malignant Neoplasms of Male Genital Organs

NCT02655965 2021-01-27

DESIGN

Jules Bordet Institute

Phase 3 Completed
54 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡